The News Review:

- Report: about 38 mln Chinese carry hepatitis C virus_English_Xinhua
- Eurofins Scientific : Eurofins expands its genomic activities
- Emerging Research Highlights How Race Ethnicity and Socio-economic…
- Exclusive stem cell centre launched
- Found in translation: Prioritising research questions in breast cancer

Report: about 38 mln Chinese carry hepatitis C virus_English_Xinhua
æ°åç’ – Nov 22, 2007
Although the virus can be eradicated or controlled in the early stages of the disease through proper therapy about 30 percent of those surveyed said there was no cure for hepatitis C. Many also confused hepatitis C with hepatitis B the CFHPC report said. Clinical research in China and abroad showed that 70 percent of the HVC carriers could be cured if diagnosed at an early stage the report said. “The whole society should work to improve the public awareness of HCV so that the carriers could be diagnosed and treated as early as possible. ” The CFHPC suggested that the government tighten controls on blood products and expand HVC testing. HCV usually spreads through contact with infected blood sex with an infected person or from mother to baby during childbirth. Editor: Wang Yan.

Eurofins Scientific : Eurofins expands its genomic activities
Boursier.com – Nov 22, 2007
These molecular biology methods have a growing usage in many sectors of the industry including food and feed safety environmental control pharmaceutical drug and diagnostic development. They are also one of the main tools currently used in life science research. Molecular-biological techniques are used to develop new generations of drugs in clinical research. They enable optimisation of the research by taking into consideration genetic differences in individuals improving effectiveness and reducing side effects. Synthetic nucleine acids are futher utilised in clinical diagnostics and also the agricultural industry to discover metastases viral infections and contamination of food. “Through these acquisitions we will together with our new partners improve our market penetration in the area of molecular-biological research” said Dr. Gilles Martin CE of Eurofins.

Emerging Research Highlights How Race Ethnicity and Socio-economic…
webwire.com – Nov 22, 2007
Carcinogenesis biomarkers epidemiology prevention cancer communications translational research treatment health economics and survivorship issues will be highlighted. The meeting is co-sponsored by the NCI Center to Reduce Health Disparities and the Minorities in Cancer Research council of the AACR. “This conference is the first of its kind in that it will address various topics in basic science clinical research population science behavioral research and cancer survivorship” said meeting co-chair John D. senior investigator and director in the Integrated Cancer Genomics Division at the Translational Genomics Research Institute. “The meeting will provide a powerful forum to identify risk factors and barriers to the reduction and elimination of cancer health disparities”lopade Rebbeck and Carpten will host a press briefing to give reporters background on the emerging field of cancer health disparities and an update on the state of the science.

Exclusive stem cell centre launched
Hindu – Nov 22, 2007
The state-of-the-art facility located at Sri Ramachandra Medical Centre at an investment of Rs five crore would exclusively cater to stem cell and bone marrow transplants for hematological and oncological disorders TRICell Vice Chairman S Abhaya Kumar told reporters here on Thursday. At a later stage TRICell would also introduce treatment methods of regenerative medicine — a concept in which stem cells were induced to differentiate into the specific cell types required to repair damaged or destroyed cell populations. He said the clinical research arm of TRICell would conduct neurological and vascular disorder clinical trials to begin with and expand its horizon to other areas in due course. Kumar said world-renowned stem cell therapists would carry out research activities at the centre and more funds would be invested for the purpose. LifeCell would set up such centres in Delhi Mumbai Kolkata and Pune by 2009.

Found in translation: Prioritising research questions in breast cancer
innovations report – Nov 22, 2007
Identifying issues deemed important by the research community could help focus translational research resources ensuring that opportunities for important clinical advances aren't missed. "This appears to be a novel way to identify the most important challenges for improving breast cancer treatment and prevention" explains Professor Dowsett. "The work will allow investigators globally to select the most relevant clinical research questions in their efforts to translate the major advances in basic science to improvements in the clinical management of this common malignancy. I am grateful to the participants from 48 countries who made this possible. " Charlotte Webber | Quelle:.